Mouse Gene Set: GOBP_ADENYLATE_CYCLASE_INHIBITING_DOPAMINE_RECEPTOR_SIGNALING_PATHWAY
For the Human gene set with the same name, see GOBP_ADENYLATE_CYCLASE_INHIBITING_DOPAMINE_RECEPTOR_SIGNALING_PATHWAY
Standard name
GOBP_ADENYLATE_CYCLASE_INHIBITING_DOPAMINE_RECEPTOR_SIGNALING_PATHWAY
Systematic name
MM5017
Brief description
An adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway initiated by dopamine binding to its receptor, and ending with the regulation of a downstream cellular process. [GOC:dph, GOC:mah, GOC:signaling, GOC:tb]
Full description or abstract
Collection
M5: Ontology GO: Gene Ontology GO:BP: GO Biological Process
Source publication
Exact source
GO:0007195
Related gene sets
External links
http://amigo.geneontology.org/amigo/term/GO:0007195
Filtered by similarity ?
Source species
Mus musculus
Contributed by
Gene Ontology (Gene Ontology Consortium)
Source platform or identifier namespace
Mouse_NCBI_Gene_ID
Dataset references
Download gene set
format: grp | gmt | xml | json | TSV metadata
Compute overlaps ?
(show collections to investigate for overlap with this gene set)
Compendia expression profiles ?
NG-CHM interactive heatmaps
(Please note that clustering takes a few seconds )
Mouse Transcriptomic BodyMap compendium
Legacy heatmaps (PNG)
Mouse Transcriptomic BodyMap compendium
Advanced query
Further investigate
these 6 genes
Show members
(show 6 source identifiers mapped to 6 genes)
Source Id
NCBI (Entrez) Gene Id
Gene Symbol
Gene Description
13489
13489
Drd2
dopamine receptor D2 [Source:MGI Symbol;Acc:M...
13490
13490
Drd3
dopamine receptor D3 [Source:MGI Symbol;Acc:M...
13491
13491
Drd4
dopamine receptor D4 [Source:MGI Symbol;Acc:M...
192176
192176
Flna
filamin, alpha [Source:MGI Symbol;Acc:MGI:95556]
224129
224129
Adcy5
adenylate cyclase 5 [Source:MGI Symbol;Acc:MG...
27374
27374
Prmt5
protein arginine N-methyltransferase 5 [Sourc...
Version history
2024.1.Mm: Updated to GO Release 2024-04-24.
See MSigDB license terms here . Please note that certain gene sets
have special access terms.